Karpas Strategies’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$298K Buy
14,412
+30
+0.2% +$596 0.09% 105
2024
Q1
$270K Sell
14,382
-110
-0.8% -$1.89K 0.08% 107
2023
Q4
$209K Sell
14,492
-111
-0.8% -$1.51K 0.07% 111
2023
Q3
$254K Buy
14,603
+32
+0.2% +$667 0.09% 103
2023
Q2
$303K Buy
14,571
+29
+0.2% +$630 0.1% 101
2023
Q1
$342K Buy
14,542
+28
+0.2% +$752 0.12% 94
2022
Q4
$405K Sell
14,514
-46
-0.3% -$1.18K 0.14% 87
2022
Q3
$341K Buy
14,560
+21
+0.1% +$634 0.13% 90
2022
Q2
$491K Buy
14,539
+19
+0.1% +$665 0.17% 79
2022
Q1
$507K Buy
14,520
+17
+0.1% +$581 0.16% 83
2021
Q4
$442K Hold
14,503
0.14% 86
2021
Q3
$529K Buy
14,503
+1,100
+8% +$35.2K 0.17% 77
2021
Q2
$406K Buy
+13,403
New +$441K 0.14% 85

Other funds holding OGN

Karpas Strategies's OGN Position: Q2 2024 in Review

Karpas Strategies increased its Organon & Co (OGN) stake by 0.21% in Q2 2024, buying an estimated $596 and bringing the position to 14,412 shares worth $298K. The position accounts for 0.09% of the portfolio, ranked #105.

Karpas Strategies first reported a position in OGN in Q2 2021 and has held it in 13 quarters since. The position peaked at $529K in Q3 2021. 724 funds tracked by Wall St. Rank hold OGN as of Q2 2024.

  • Karpas Strategies held 14,412 shares of Organon & Co worth $298K as of Q2 2024.
  • Karpas Strategies bought 30 Organon & Co shares in Q2 2024, an estimated $596.
  • Organon & Co made up 0.09% of Karpas Strategies's portfolio in Q2 2024, its #105 holding.
  • Karpas Strategies first reported a position in Organon & Co in Q2 2021 and has held it in 13 quarters since.
  • Karpas Strategies's Organon & Co position peaked at $529K in Q3 2021.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q2 2024.

Based on Karpas Strategies's 13F filing for Q2 2024, filed 30 Jul 2024.